This report highlights that a hybrid model of engagement, blending both virtual and face-to-face interactions, has become the new normal for physicians and pharmaceutical companies.
While virtual channels like webinars and video calls are firmly established, in-person interactions have also returned to pre-pandemic levels.
The key takeaway is that most healthcare professionals are comfortable adapting their interaction channel to suit their needs, yet many pharma companies haven't fully adapted to this hybrid approach.
The report stresses that companies need to personalise their engagement mix and embrace digital infrastructure to effectively interact with physicians in this evolving landscape.
Related Articles
Beyond the Mass Email: The Imperative of Personalization in Pharma
Why HCPs are tuning out generic communications and how personalization is transforming engagement.
Pharma Marketing: What's Working for HCPs in 2025
Key insights from pharma marketing leaders on effective HCP engagement strategies.
How Omnichannel is Transforming Pharma Engagement
The digital transformation journey and its impact on healthcare provider relationships.